Cite
APA Citation
How, J., Ren, S., Lombardi‐Story, J., Bergeron, M., Foster, J., Amrein, P. C., Brunner, A. M., Fathi, A. T., Hock, H., Khachatryan, A., Kikuchi, H., Ng, M. R., Moran, J., Narayan, R., Neuberg, D., Ramos, A., Som, T., Vartanian, M., Chen, Y., Duda, D. G., & Hobbs, G. S. (2022). a nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignancies. EJHaem, 3(2), 434–442. http://access.bl.uk/ark:/81055/vdc_100155163644.0x000004